Literature DB >> 13124352

Phenylbutazone (butazolidin) in gout.

W C KUZELL, R W SCHAFFARZICK, W E NAUGLER, G GAUDIN, E A MANKLE, B BROWN.   

Abstract

Entities:  

Keywords:  ANALGESICS/therapeutic use; GOUT/therapy

Mesh：

Substances：

Year:  1954        PMID： 13124352     DOI： 10.1016/0002-9343(54)90336-8

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  5 in total

1.  Evaluation of uricosuric agents in chronic gout.

Authors:  M A OGRYZLO; J HARRISON
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

2.  Effect of a phenylbutazone analog (4-[phenylthioethyl]-1, 2-diphenyl 3, 5-pyrazolidinedione) on urate clearance and other discrete renal functions in gouty subjects; evaluation as uricosuric agent.

Authors:  T F YU; B C PATON; T CHENKIN; J J BURNS; B B BRODIE; A B GUTMAN
Journal:  J Clin Invest       Date:  1956-04       Impact factor: 14.808

3.  Recent advances in rheumatic diseases.

Authors:  E W BOLAND
Journal:  Calif Med       Date:  1955-02

4.  Metabolic effect of phenylbutazone in gouty and non-gouty arthritis.

Authors:  E R HUFFMAN; G M WILSON; C J SMYTH; R HILL
Journal:  Ann Rheum Dis       Date:  1954-12       Impact factor: 19.103

5.  Current concepts of hyperuricemia and gout.

Authors:  J R Klinenberg
Journal:  Calif Med       Date:  1969-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.